Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL1797831 | 1.00 | DNM1 (0.44) | DNM1SPHK1LPAR1LPAR3LPAR2 | |
| Trimethylammonium SCHEMBL10884276 | 1.00 | DNM1 (0.44) | DNM1SPHK1LPAR1LPAR3LPAR2 | |
| SCHEMBL28213352 | 0.91 | DNM1 (0.45) | DNM1LPAR1LPAR3LPAR2THRB | |
| SCHEMBL8113079 | 0.84 | — | — | |
| SCHEMBL27478603 | 0.78 | DNM1 (0.47) | DNM1LPAR1LPAR3LPAR2THRB | |
| SCHEMBL9865981 | 0.78 | DNM1 (0.47) | DNM1LPAR1LPAR3LPAR2THRB | |
| SCHEMBL9339607 | 0.78 | DNM1 (0.47) | DNM1LPAR1LPAR3LPAR2THRB | |
| SCHEMBL28222439 | 0.77 | USP2 (0.47) | DNM1LPAR1LPAR3LPAR2THRB | |
| Trimethylammonium SCHEMBL29030815 | 0.76 | DNM1 (0.41) | DNM1SPHK1LPAR1LPAR3LPAR2 | |
| SCHEMBL27479414 | 0.76 | DNM1 (0.43) | DNM1LPAR1LPAR3LPAR2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130112217-A1 | CONDITIONING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2013-05-09 | — | — | US | disclosed |
| EP-2512421-A2 | CONDITIONING COMPOSITION FOR HAIR | Kao Germany GmbH (DE) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011072853-A2 | CONDITIONING COMPOSITION FOR HAIR | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130112217-A1 | CONDITIONING COMPOSITION FOR HAIR | AR, H1-4, H1-10 | DNM1 4579/4885SPHK1 3385/4885LPAR1 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.